Skip to content

Public FDA record

Z-0810-2007: Roche PTH (parathyroid hormone test system) for use in conjunction with Roche cobas e 411, cobas e 601, E

Recall record Z-0810-2007 for Roche Diagnostics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0810-2007
Company in FDA record
Roche Diagnostics Corp.
FDA classification date
May 16, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Negative bias caused by hemolysis interference at the low end of the reference range could cause erroneous diagnosis of hypoparathyroidism.

Source facts

Action
The firm issued a letter dated 04/19/07 to all users informing them of the change in the hemoglobin interference claim.
Initiated
2007-04-19
Root cause
Other
Terminated
2008-06-11
Distribution
Nationwide.
Recall number
Z-0810-2007
Recall status
Terminated
CDRH record ID
51475
FDA classified
2007-05-16
Recall event number
37761

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗